ArticlePreventive medicine reports2025
Awareness and acceptability of herpes zoster vaccination in people living with HIV.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- More relevant than ever: Celebrating a decade ofPreventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The recombinant herpes zoster vaccine is recommended for aging populations to prevent herpes zoster. We aimed to assess awareness of herpes zoster and acceptance of the herpes zoster vaccine acceptance among people living with HIV (PLWH). Methods: We conducted a written survey among PLWH attending an HIV outpatient clinic in Brussels from March 2022 to April 2023. Participation was voluntary. We collected epidemiological data, assessed knowledge of herpes zoster and opinion about herpes zoster vaccine and vaccination in general. We described the surveyed cohort and reported their attitudes toward vaccination. Herpes zoster vaccine acceptance and general vaccine acceptance were defined as two binary outcome variables. We performed binary logistic regression to identify factors associated with vaccine acceptance. Results: A total of 327 patients completed the questionnaire. While 64 % reported being aware of herpes zoster, only one third reported a link between herpes zoster and varicella infection. The majority (77.1 %) declared being in favour of overall vaccination. Willingness to be vaccinated (regardless of vaccine type) was the factor associated with herpes zoster vaccine acceptance. General vaccine acceptance was associated with the belief that vaccination is useful for preventing infectious diseases. Conclusions: Knowledge and awareness about herpes zoster were low among PLWH surveyed. Herpes zoster vaccine acceptance was more related to general attitudes toward vaccination rather than specific knowledge about herpes zoster.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.